Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,341,761
+$407,623 QoQ
Shares Held
9,306
+4.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.55%
of 13F equity value
Holder Rank
#1,843
of 4,153 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 70%
Shared 30%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Argyle Capital Partners, LLC holds $5,444,856 across 5 Drug Manufacturers - General names. ABBV ranks #1 (43.0% of the industry book) .
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,341,761 | 9,306 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,934,138 | 8,893 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,032,875 | 8,897 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,193,609 | 9,474 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,770,814 | 9,540 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,022,706 | 9,654 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $1,825,689 | 10,274 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||